Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Tellurian $500 million at-the-market offering
The shares are listed on the NYSE
OPAL Fuels warrant exchange offer
A total of 13,240,756 warrants were exchanged for stock
Gaming and Leisure Properties $1 billion at-the-market offering
The shares are listed on Nasdaq
Novavax $175.25 million convertible senior notes offering
The 5% convertible notes are due 2027
Terns Pharmaceuticals $86 million stock offering
The stock is listed on the Nasdaq Global Select Market
Chart Industries $1.97 billion notes offering
The high-yield senior notes are due 2030 and 2031
Royal Schiphol €515 million sale of shares in Aéroports de Paris
We advised the selling shareholder on the transaction
Coherus BioSciences $150 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
Skymark Airlines ¥37.4 billion IPO
The shares are listed on the Tokyo Stock Exchange